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Expanded 3D Nanofiber Scaffolds: Cell Penetration, 
Neovascularization, and Host Response
Jiang Jiang, Zhuoran Li, Hongjun Wang, Yue Wang, Mark A. Carlson, 
Matthew J. Teusink, Matthew R. MacEwan, Linxia Gu, and Jingwei Xie*
DOI: 10.1002/adhm.201600808
Herein, a robust method to fabricate expanded nanofiber scaffolds with 
controlled size and thickness using a customized mold during the modified 
gas-foaming process is reported. The expansion of nanofiber membranes 
is also simulated using a computational fluid model. Expanded nanofiber 
scaffolds implanted subcutaneously in rats show cellular infiltration, whereas 
non-expanded scaffolds only have surface cellular attachment. Compared to 
unexpanded nanofiber scaffolds, more CD68+ and CD163+ cells are observed 
within expanded scaffolds at all tested time points post-implantation. More 
CCR7+ cells appear within expanded scaffolds at week 8 post-implantation. 
In addition, new blood vessels are present within the expanded scaffolds at 
week 2. The formed multinucleated giant cells within expanded scaffolds are 
heterogeneous expressing CD68, CCR7, or CD163 markers. Together, the 
present study demonstrates that the expanded nanofiber scaffolds promote 
cellular infiltration/tissue integration, a regenerative response, and neovas-
cularization after subcutaneous implantation in rats. The use of expanded 
electrospun nanofiber scaffolds offers a promising method for in situ tissue 
repair/regeneration and generation of 3D tissue models/constructs.
bioactive signaling molecules and phar-
maceutical agents capable of positively 
influencing cellular behavior.[4] Nano-
topographic cues rendered by electrospun 
nanofibers have demonstrated the ability 
to guide cellular morphology, migration, 
and differentiation.[5] However, one major 
drawback that lies in traditional electro-
spun nanofiber membranes is the small 
pore size resulting from tightly packed 
nanofiber layers, which limits cellular 
infiltration and 3D tissue formation.[6] 
3D scaffolds composed of electrospun 
nanofibers that promote cellular infiltra-
tion therefore may represent an improved 
synthetic matrix for use in tissue repair/
regeneration, and provide a better mimic 
for both the structure and composition of 
targeted tissues.[7]
In order to improve the modeling of 
native tissue structure, many attempts 
have been made to fabricate 3D elec-
trospun nanofiber scaffolds. Jun and 
co-workers designed a unique collector consisting of a 
grounded spherical dish and an array of needle-like probes 
for creation of a focused, low density, uncompressed poly(ε-
caprolactone) (PCL) nanofiber scaffold.[8] In order to promote 
electron transfer from deposited fibers to the collector and 
achieve repulsion between deposited fibers and the collector 
during electrospinning, Yang and co-workers used a nega-
tively charged spinneret and a positively charged collector 
1. Introduction
Electrospinning is an enabling technology that can produce a 
matrix reminiscent of extracellular matrix found in a variety of 
tissues and organs, which are synthesized and hierarchically 
organized into fibrillar form with fiber dimensions down to 
nanometer scale.[1–3] Electrospun nanofibers can also provide 
a large surface area-to-volume ratio ideal for immobilizing 
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board, electrospinning zein, and keratin scaffolds with fibers 
oriented randomly and evenly in 3D.[9] Based on a similar 
principle, Jang and co-workers added salts to a polymer solu-
tion prior to electrospinning and produced a sponge nanofiber 
matrix composed of multilayered nanofiber sheets.[10] Kwon 
and co-workers exposed 2D poly(l-lactide) (PLLA) nanofiber 
membranes to ultrasonication with different times and 
obtained 3D nanofiber scaffolds with adjustable pore size and 
thickness with longer treatment.[11] Alsberg and co-workers 
further combined fiber–fiber charge repulsions and ultra-
sonication to fabricate highly porous alginate nanofiber 
scaffolds.[12] Unfortunately, most studies have been limited to 
the fabrication of 3D nanofiber scaffolds composed of random 
nanofibers and/or certain materials. The resultant scaffolds 
often had insufficient thickness, restricted geometries, and/
or uncontrolled porosity.[8–12] These fabricated scaffolds were 
also associated with unordered structures and lack of nano-
topographic cues that are critical for regeneration of highly 
organized tissues such as tendon, nerve, and muscle.[13] In 
addition, most of these 3D nanofiber scaffolds were only 
examined either in vitro or in vivo with respect to cellular 
infiltration, lacking the characterization of host response and 
neovascularization.
Our recent study reported a modified gas-foaming 
approach to expand electrospun nanofiber membranes in the 
third dimension.[13] The expanded nanofiber scaffolds had 
significantly higher porosity than traditional 2D nanofiber 
membranes, while maintaining aligned nanotopography. 
The expanded scaffolds also had a layered structure with 
gap widths and layer thicknesses controllable on micrometer 
scale, ideal for cell seeding and penetration. Robust cellular 
infiltration and proliferation within expanded nanofiber 
scaffolds were demonstrated in vitro. However, the usable 
size and precise control of scaffold thickness were not fully 
realized in previous work.[13] For example, the largest size 
of fiber samples tested for expansion was ≈1 cm × 1 cm.[13] 
Larger sizes of nanofiber membranes were not examined. 
Furthermore, the thickness of scaffolds fabricated was pri-
marily dependent on processing time. In order to optimize 
this process for use in the production of scaffolds for tissue 
repair/regeneration, a greater range of scaffold sizes (width, 
length) and thicknesses are required. More precise control 
of scaffold thickness is also desired in order to optimize the 
translational potential of fabricated 3D nanofiber matrices. 
Therefore, a robust method capable of producing expanded 
electrospun nanofiber scaffolds with increased size and pre-
cise control of thickness is greatly needed. In addition, the 
previous study only tested the in vitro cellular infiltration 
for expanded nanofiber scaffolds.[13] The in vivo response of 
expanded nanofiber scaffolds largely remains unknown. The 
objectives of the present study were to fabricate expanded 
nanofiber scaffolds with increased size and precise control 
of thickness, and to examine the cellular infiltration, host 
response, and neovascularization of expanded scaffolds after 
subcutaneous implantation in rats. The findings of this study 
aim to provide insight into the design of 3D biomimetic 
scaffolds for tissue repair and regeneration in situ and engi-
neering 3D tissue models/constructs in vitro.
2. Results
2.1. Fabrication and Characterization of Expanded 
Nanofiber Scaffolds
Previously we demonstrated that electrospun nanofiber mats 
can be expanded in the third dimension after treatment with 
aqueous NaBH4 solution.[13] However, the working size and 
thickness control of these expanded scaffolds were some-
what limited. In the present report, we have described a 
robust approach for fabrication of expanded nanofiber scaf-
folds with both a greater mat size and a precise control of 
thickness by using a customized glass mold (Figure 1). We 
were able to expand nanofiber scaffolds with a starting mat 
size of 80 mm × 80 mm (increased from 10 mm × 10 mm; 
see Figure S1, Supporting Information). In addition, the pre-
cise thickness control of these expanded scaffolds was achieved 
using pre-designed glass spacers (Figure 1a).
Figure 2a shows the photographs of an unexpanded 
nanofiber mat (left) and freeze-dried, expanded nanofiber scaf-
folds (30 mm × 50 mm) with thicknesses of 3 mm (middle) 
and 10 mm (left). Figure 2b,c shows the photographs of the 
sterilized 3 and 10 mm thick scaffolds immersed in saline 
before subcutaneous implantation. Figure 2d shows scanning 
electron microscopy (SEM) images of the cross section of an 
unexpanded PCL nanofiber mat, indicating that the fiber mat 
prior to expansion was composed of densely packed random 
nanofibers. Figure 2e,f shows SEM images of the cross sections 
of expanded 3 and 10 mm thick nanofiber scaffolds, displaying 
layered structures. Increased gap distances were observed for 
thicker nanofiber scaffolds. However, it seems that there was not 
much difference between the layer thicknesses of 3 and 10 mm 
thick nanofiber scaffolds. Based on SEM images, we also quan-
tified the distribution of gap distances and layer thicknesses for 
the cross sections of 3 and 10 mm thick nanofiber scaffolds. 
Figure 2g shows the distributions of gap distances for the cross 
sections. Thicker scaffolds had larger gap distances as the peak 
shifted to the right with increasing the thickness. The gap 
distances corresponding to the peaks were 10 and 20 μm on 
the cross sections of 3 and 10 mm thick nanofiber scaffolds. 
Interestingly, the distributions of layer thicknesses were similar 
(Figure 2h). The layer thickness corresponding to the peak was 
around 10 μm.
2.2. Simulation of Expanding Process of Nanofiber Membranes
The volume fractions of the gas during the expanding process, 
including the bubble nucleation, growth, and coalescence, were 
described in Figure 3. The volume of fluid (VOF) model tracked 
the volumes of gas in each numerical grid. Specifically, the 
blue region corresponds to near zero volume fraction of gas, 
indicating a liquid phase. The red region with a unity volume 
fraction indicated a gas phase. Here we tracked the gas–liquid 
interface based on a given volume fraction of 0.5, i.e., each grid 
at the interface that is half full with gas. Five inlets were con-
structed at the bottom layer to initiate the gas flow and mimic 
the gas bubble nucleation (Figure S2, Supporting Information). 
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It is clear that the nucleated bubbles grow bigger with the 
continued production of gas till coalescence of adjacent bubbles 
starting at 0.0003 s. A short distance between two nuclea-
tion sites led to earlier gas bubble coalescence. At 0.0011 s, a 
bubble layer was formed to further expand the nanofiber scaf-
folds. This process was also speculated in our previous work.[13] 
Results also demonstrated that gas bubbles bridging two layers 
of scaffold were noncircular, which was different from clas-
sical free-floating gas bubbles. This could be due to the bubble 
surface tension and the pressure gradient at both ends of the 
scaffold. The flow dynamics of the expanding process could be 
further used to optimize and control the spatial structure of 
nanofiber scaffolds.
2.3. Qualitative Histology Analysis
In order to examine the cellular infiltration after subcuta-
neous implantation, we evaluated histological sections of the 
implanted PCL scaffolds and surrounding tissues with hema-
toxylin and eosin (H&E) and Masson trichrome staining. 
Figure 4 shows H&E staining of various scaffolds with 
surrounding tissues after subcutaneous implantation for 1, 2, 4, 
and 8 weeks. Unexpanded scaffolds only exhibited limited cel-
lular penetration (Figure 4), except at occasional cracks within 
the scaffolds. In the expanded 3 mm thick scaffolds, cellular 
penetration was present from week 1; near complete penetra-
tion was present by week 8. For the expanded 10 mm thick 
scaffolds, complete cellular penetration was present at week 8. 
We also observed new blood vessel formation within expanded 
scaffolds at week 2, 4, and 8, as indicated by the red blood cells 
(insets in Figure 4). In contrast, no blood vessel formation was 
noted within the unexpanded scaffolds.
Figure 5 shows Masson’s trichrome staining of scaffolds 
with surrounding tissue after explantation. The cellular 
infiltration and new blood vessel formation showed a trend 
similar to the H&E staining (Figure 4). In addition, initial col-
lagen encapsulation of the implants was evident one week 
after implantation. Qualitatively, the thickness of the collagen 
capsule on unexpanded scaffolds tended to increase with time; 
this progression was not apparent on the expanded scaffolds. 
In addition, within-scaffold collagen deposition by infiltrated 
cells was observed within the expanded nanofiber scaffolds at 
week 4 and 8 (Figure 5). Multinucleated giant cells were present 
at the edge of unexpanded scaffolds and 3 mm thick expanded 
scaffolds at week 1, but not in the 10 mm expanded scaffolds 
(Figure 6). The giant cells in unexpanded scaffolds mostly were 
observed on the scaffold edges, while giant cells in expanded 
random scaffolds mostly were adjacent to the newly formed 
blood vessels. Similar results were observed for expanded 
aligned PCL scaffolds (Figure S3, Supporting Information).
2.4. Quantification of Cell Infiltration, Neovascularization, 
and Host Response
In order to fully understand the cellular infiltration, neovascu-
larization, and host response, we quantified the depth of cell 
penetration into scaffolds, blood vessel density within scaffolds, 
the thickness of collagen fibrous capsules, and the number of 
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Figure 1. Schematic illustration of the fabrication of expanded PCL nanofiber scaffolds. a) A customized mold was made by a pair of glass sheets and 
spacers, which was assembled by glue. A piece of plasma-treated PCL fiber mat was placed at the center of the mold. b) The PCL fiber mat together 
with the mold was expanded in 1 m NaBH4 solution for 1 h at room temperature. c) The expanded PCL nanofiber scaffold was rinsed, vacuumed, and 
freeze-dried using a lyophilizer. d) The glass mold was gently removed and the expanded PCL nanofiber scaffold was ready to be sterilized and used 
for implantation.
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giant cells per implant (Figure 7). The unexpanded nanofiber 
scaffolds showed a marginal increase in the depth of cell pene-
tration from around 49.9 μm at week 1 and 2 to 80 μm at week 4 
and 8 after implantation (Figure 7a). The expanded 3 mm thick 
scaffolds showed a steady increase of penetration depth from 
67.1 μm at week 1, to 128.7 μm at week 2, to 171.5 μm at 
week 4, and further to 314.3 μm at week 8 (Figure 7a). Simi-
larly, the depth of cell penetration within expanded 10 mm 
thick scaffolds increased from 90.2 μm at week 1, to 94.3 μm 
at week 2, to 186.8 μm at week 4, and further to 441.1 μm at 
week 8 (Figure 7a). The aligned expanded 3 mm thick scaffolds 
showed a comparable depth of penetration as 3 and 10 mm 
thick scaffolds at week 4 and 8. No newly formed blood ves-
sels were seen within unexpanded scaffolds at all tested time 
points (Figure 7b). Differently, expanded 3 and 10 mm thick 
scaffolds showed a dramatic increase in blood vessel density 
from zero at week 1, to 11.0 and 13.4 vessels mm−2 at week 2, 
to 16.9 and 30.3 vessels mm−2 at week 4, and further to 22.7 
and 31.0 vessels mm−2 at week 8 (Figure 7b). Aligned expanded 
3 mm thick scaffolds showed a similar level of blood vessel den-
sity as 3 and 10 mm thick scaffolds.
The unexpanded nanofiber scaffolds showed an increase 
in the thickness of collagen fibrous capsules from 549.7 μm 
at week 1, to 673.2 μm at week 2, to 668.0 μm at week 4, and 
further to 840.6 μm at week 8 (Figure 7c). In contrast, the thick-
nesses of capsules for expanded 3 mm thick scaffolds decreased 
from 523.7 μm at week 1, to 437.0 μm at week 2, to 290.0 μm 
at week 4, and further to 348.9 μm at week 8 (Figure 7c). The 
thickness of fibrous capsules of expanded 10 mm thick 
scaffolds was comparable to that of 3 mm thick scaffolds 
(Figure 7c). For the aligned expanded 3 mm thick scaffolds, the 
thickness of collagen fibrous capsules showed a slight increase 
from 128.9 μm at week 1 to 254.2 μm at week 2, then remained 
almost constant at week 4 and week 8 (Figure 7c).
The number of giant cells per implant for unexpanded 
nanofiber scaffolds was about 16 at week 1, 9 at week 2, 3 at 
week 4, and 6 at week 8 (Figure 7d). In comparison, the number 
of giant cells per implant for expanded 3 mm thick scaffolds 
Adv. Healthcare Mater. 2016, 
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Figure 2. Morphological and structural characterizations of unexpanded and expanded random nanofiber scaffolds. a) Photographs of random PCL 
nanofiber scaffolds prior to and after treatment with 1 m NaBH4 for 1 h using 3 and 10 mm molds. b,c) Photographs of expanded 3 and 10 mm thick 
scaffolds in saline. SEM images showing the cross sections of random PCL fiber mats d) before and after expansion with e) 3 and f) 10 mm molds. 
The scale bar in (d)–(f) is 20 μm. g) The distributions of gap distances between adjacent layers of expanded 3 and 10 mm thick nanofiber scaffolds. 
h) The distributions of layer thicknesses of expanded 3 and 10 mm thick nanofiber scaffolds. Both the gap distance and layer thickness were quantified 
using the Image J software based on SEM images.
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was 16 at week 1, 28 at week 2, 31 at week 4, and 50 at week 8 
(Figure 7d). Expanded 10 mm thick scaffolds showed a compa-
rable number of giant cells per implant as 3 mm thick scaffolds 
at week 4 and 8 (Figure 7d). Differently, the number of giant 
cells per implant for aligned 3 mm thick scaffolds increased 
from week 1 (24) to week 2 (44) and then decreased to 20 at 
week 4, and further to 13 at week 8 (Figure 7d).
2.5. Immunostaining of Macrophage Phenotype
In order to understand the phenotypes of infiltrated macro-
phages in scaffolds or in the surrounding areas, we performed 
immunostaining of scaffolds and surrounding tissues after 
explantation using three macrophage markers against CCR 
7 (a surface marker for M1 macrophage phenotype), CD163 
(a surface marker for M2 macrophage phenotype), and CD68 
(a general macrophage marker).[14,15] Figures S4–S7 (Sup-
porting Information) show the spatiotemporal distribution 
of all macrophages, M1 macrophages, and M2 macrophages 
within scaffolds and surrounding tissues. As expected, unex-
panded scaffolds displayed limited macrophage infiltration 
(Figure S4, Supporting Information), mostly appearing at week 
4 and 8. In the expanded scaffolds, macrophages penetration 
into scaffolds was apparent at week 1, and increased thereafter. 
The 10 mm thick scaffolds showed the greatest number of pen-
etrating macro phages at week 8 (Figure S4, Supporting Infor-
mation), with a similar spatiotemporal distribution of M1 and 
M2 phenotypes (Figures S5–S7, Supporting Information).
2.6. Quantification of Macrophage Phenotype
In order to better understand the phenotypes of infiltrated 
macrophages, we quantified the number of macrophages 
in each phenotype per immunohistochemical image (40×) 
(Figure 8a–c). The unexpanded nanofiber scaffolds showed 
a slight increase in the number of CD68+ cells from 30 at 
week 1, to 33 at week 2, to 38 at week 4, and decreased to 24 at 
week 8 (Figure 8a). Expanded 3 mm thick scaffolds showed a 
constant number (54) of CD68+ cells during the testing period. 
In contrast, 10 mm and aligned 3 mm thick scaffolds showed a 
dramatic increase in the number of CD68+ cells from 49 and 45 
at week 1, to 56 and 46 at week 2, to 85 and 78 at week 4, and 
further to 88 and 91 at week 8 (Figure 8a).
The number of CCR7+ cells for unexpanded nanofiber scaf-
folds was 40 at week 1, 41 at week 2, 42 at week 4, and 15 at 
week 8 (Figure 8b). Expanded 3 mm thick scaffolds showed a 
slight increase in the number of CCR7+ cells from 39 at week 1, 
to 48 at week 2, then decreased to 34 at week 4, and further to 
25 at week 8. In contrast, 10 mm and aligned 3 mm thick scaf-
folds showed a gradual increase in the number of CCR7+ cells 
from 31 and 32 at week 1, to 43 and 39 at week 2, to 47 and 
58 at week 4, and further to 57 and 61 at week 8 (Figure 8b).
The numbers of CD163+ cells per snap shot for unexpanded 
nanofiber scaffolds were 27, 26, 30, and 20 at week 1, 2, 4, and 
8 (Figure 8c). The numbers of CD163+ cells for expanded 3 mm 
scaffolds were similar at different time points (41, 49, 46, and 
49 CD163+ cells per snap shot at week 1, 2, 4, and 8). Expanded 
10 mm scaffolds showed an increase in the number of CD163+ 
cells per snap shot from 46 at week 1, to 47 at week 2, to 62 
at week 4, and further to 72 at week 8 (Figure 8c). The corre-
sponding numbers of CD163+ cells for the aligned 3 mm thick 
scaffolds were 35, 32, 48, and 57 at week 1, 2, 4, and 8. Figure 8d 
shows that expanded 10 mm thick scaffolds had higher ratios 
of M2/M1 at week 1 and 4 compared to unexpanded scaffolds. 
However, no significant difference in the ratio of M2/M1 was 
observed between the tested groups at week 8. In addition, 
expanded 3 mm thick scaffolds showed higher M2/M1 ratio 
than that of unexpanded counterparts.
2.7. Heterogeneity of Multinucleated Giant Cells
To understand the heterogeneity of multinucleated giant cells, 
we further analyzed the corresponding high-magnification 
images of Figures S4–S6 (Supporting Information). For random 
nanofiber scaffolds including unexpanded and expanded, the 
formed multinucleated giant cells expressed CD 68, CCR 7, 
and CD 163 markers (Figures S8–S10, Supporting Informa-
tion). The expanded, aligned nanofiber scaffolds showed 
similar results (Figure S11, Supporting Information). We also 
quantified the number of CD 68+, CCR 7+, CD 163+, and the 
ratio of CD163+/CCR7+ multinucleated giant cells (Figure S12, 
Adv. Healthcare Mater. 2016,  
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membranes.
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Supporting Information). Multinucleated giant cells expressed 
heterogeneous markers including CD 68, CCR7, and CD 163 
(Figure S12a–c, Supporting Information). The number of 
CD163+ giant cells was usually higher than that of CCR7+ giant 
cells except for expanded 10 mm thick random scaffolds at 
week 2 and unexpanded scaffolds at week 4 (Figure S12d, Sup-
porting Information). Expanded random nanofiber scaffolds 
with 3 mm thick showed the highest ratios of CD163+/CCR7+ 
multinucleated giant cells from week 2 to week 8 among the 
tested groups (Figure S12d, Supporting Information).
2.8. Immunostaining of Inflammatory and 
Anti-Inflammatory Cytokines
To further understand the effect of cytokines produced within 
scaffolds or in surrounding areas on the tissue regeneration, 
we performed immunostaining of scaffolds and surrounding 
tissues after explantation at week 1, 2, 4, and 8 using three 
different markers against IL-4 and IL-10 (anti-inflammatory 
cytokines) and TNF-α (pro-inflammatory cytokine).[16,17] 
Figures S13–S16 (Supporting Information) show the spatiotem-
poral distribution of IL-4, IL-10, and TNF-α within scaffolds 
and surrounding areas. As expected, unexpanded scaffolds 
only displayed limited infiltration for IL-4 (Figures S13 and 
S16, Supporting Information), IL-10 (Figures S14 and S16, 
Supporting Information), and TNF-α (Figures S15 and S16, 
Supporting Information), and their secretion level remained 
unchanged from week 1 to week 8. The IL-4 positive staining 
mainly located at the surrounding area of unexpanded scaffolds. 
For expanded scaffolds, IL-4 cytokines started expressing within 
the scaffolds from week 1 (Figure S13, Supporting Informa-
tion). More IL-4 cytokines were accumulated within expanded 
scaffolds with increasing the implantation time (Figure S13, 
Adv. Healthcare Mater. 2016, 
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Figure 4. H&E staining of random PCL nanofiber scaffolds and surrounding tissues. The unexpanded (raw) and expanded 3 and 10 mm thick nanofiber 
scaffolds were subcutaneously implanted to rats for 1, 2, 4, and 8 weeks. Insets show high magnification of green square areas in the corresponding 
images.
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Supporting Information). Obviously, the 10 mm thick scaf-
folds showed the highest level of IL-4 secretion at week 8 
(Figures S13 and S15, Supporting Information). Intriguingly, 
IL-10 and TNF-α positive staining showed a similar spatiotem-
poral distribution within scaffolds as IL-4 (Figures S14–S16, 
Supporting Information). However, the level for TNF-α staining 
seemed much lower than that of IL-4 and IL-10.
3. Discussion
For tissue repair/regeneration, scaffolds/implants may play 
an important role for homing cells from surrounding healthy 
tissues and form new tissues to repair the defected tissues.[18] 
Therefore, for sucessful in situ tissue regeneration, promoting 
cell ingrowth is one of the prerequisites for an ideal 3D scaffold. 
Studies have shown that cell infiltration is mainly determined 
by the architecture or structure of scaffolds.[19] This is, in par-
ticular, critical for synthetic scaffolds as cells often fail to 
immediately disintegrate the artificial extracellular matrices for 
migration.[19] Hence, cell ingrowth greatly relies on the porosity 
and pore size of scaffolds, which is especially true for non-biode-
gradable or slowly biodegradable materials. In a recent study, 
Jang and co-workers reported the cell infiltration within layered 
PCL nanofiber scaffolds after subcutaneous implantation in 
nude mice for six weeks, which were produced by electrospin-
ning highly conductive solutions with additives of ionic salts.[10] 
Cellular infiltration was observed, however, only one time point 
(six weeks) was examined. In addition, the porosity and the 
distribution of gap distances between adjacent layers were not 
reported.[10] The present study demonstrated the fabrication 
of expanded 3 and 10 mm nanofiber scaffolds with porosities 
of ≈90% and ≈100%, respectively. The gaps between most 
adjacent layers ranged from several micrometers to ≈100 μm 
Adv. Healthcare Mater. 2016,  
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Figure 5. Masson’s trichrome staining of random PCL nanofiber scaffolds and surrounding tissues. Masson’s trichrome staining indicates collagen in 
blue, nuclei in black, and cytoplasm and keratin in red. The unexpanded (raw) and expanded 3 and 10 mm thick nanofiber scaffolds were subcutane-
ously implanted to rats for 1, 2, 4, and 8 weeks. Insets show high magnification of green square areas in the corresponding images.
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(Figure 2g). The dynamic process of cell penetration was shown 
from week 1 to week 8, suggesting that cells may fully pene-
trate throughout the whole scaffold within eight weeks, mainly 
dependent on the porosity (Figures 4 and 5). Cells penetrated 
throughout the whole expanded 3 and 10 mm thick random 
scaffolds within eight weeks. The aligned expanded 3 mm 
thick scaffolds showed a similar penetration depth as expanded 
3 and 10 mm thick random scaffolds at week 8. In addition, 
the unexpanded PCL nanofiber scaffolds exhibited very limited 
cellular infiltration on the surface layer, which agreed well with 
previous reports.[13]
Sufficient oxygen and nutrient transport to the infiltrated 
cells within scaffolds is the key to form functional tissues in 
clinically relevant dimensions.[20] Therefore, another impor-
tant aspect for in situ tissue regeneration is neovascularization. 
Many attempts have been made to promote vascularization 
including scaffold design, endothelial cell pre-seeding, and 
incorporation of bioactive molecules.[21] Among them, the pore 
architecture and porosity of scaffolds play a critical role on the 
formation of new blood vessles via sprouting from host vas-
culature.[22] Beier and co-workers examined the actual pattern 
of vascularization in PCL/collagen nanofiber scaffolds using 
micro-CT scans and found the aligned scaffold showed a signif-
icantly smaller number of sprouting vessels but vascularization 
in the center of the constructs occurred considerably earlier 
than in the nonwoven scaffold.[23] In a separate study, Andreo-
poulos and co-workers showed that aligned electrospun gelatin 
nanofibers containning bFGF had the highest vessel density 
(33 vessels mm−2) comparing to other groups including aligned 
fibers and random fibers with and without containing bFGF 
(5 vessles mm−2) after implantation in the mouse’s hindlimb 
for 21 d.[24] Park and co-workers also examined the vasculari-
zation of 1–1.5 mm thick ten-layered PCL/collagen nanofiber 
scaffolds formed by manually folding after subcutaneous 
Figure 6. Multinucleated giant cells after random PCL nanofiber scaffold implantation. Masson’s trichrome staining of random PCL nanofiber scaffolds 
after rat subcutaneous implantation. The rats were scarified at week 1, 2, 4, and 8 after surgery. Giant cells indicated by green arrows were found around 
and inside of PCL nanofiber scaffolds.
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implantation in rats.[25] Dunn and co-workers developed a 
laser cutting pores in traditional nanofiber membranes for 
enhancement of vascular ingrowth.[26] In this work, no blood 
vessels were observed within unexpanded nanofiber scaffolds 
at all time points because of very limited cellular infiltration 
on the surface layer. Within expanded PCL nanofiber scaffolds 
Figure 7. Quantification of histological analysis of PCL nanofiber scafflods after subcutaneous implantation. a) Cell penetration, b) blood vessels 
density, c) capsule thickness, and d) number of giant cells. The values were obtained by measuring six scanning images at 40× (objective lense) 
magnification for each specimen.
Figure 8. Quantification of immunhistological analysis of PCL nanofiber scafflods after subcutaneous implantation. a) CD 68, b) CCR 7 (M1), c) CD 
163 (M2) immunpositve cells, and d) ratio of number of CD163 positive cells (M2)/number of CCR7 positive cells (M1). The values were obtained by 
measuring six scanning images at 40× (objective lense) magnification for each specimen.
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new blood vessels appeared at week 2 and blood vessel den-
sity increased with increasing implantation time and reached 
30 vessels mm−2 at week 8, which is comparable to the aligned 
gelatin nanofibers containing bFGF (33 vessels mm−2). In addi-
tion, expanded 10 mm thick scaffolds usually showed higher 
number of blood vessels per unit area within scaffolds than that 
of 3 mm thick ones (Figure 7b). The blood vessel density within 
aligned expanded 3 mm thick scaffolds was similar to that of 
10 mm thick scaffolds at week 4 and 8.
Implants require tissue engraftment and vascularization to 
generate functional tissues for replacement/repair/regenera-
tion. Host response to implantated scaffolds is very important 
to determine their success after implantation. The biological 
response has been examined on various biomaterials with dif-
ferent sizes, compositions, and shapes.[27] However, the host 
respone to electrospun nanofiber scaffolds was not fully illus-
trated and most of work was limited to the investigation of 
traditional 2D electrospun nanofiber membranes. Chew et al. 
examined host response of PCL nanofiber membranes and 
found that aligned nanofibers can minimize host response, 
enhance tissue-scaffold integration, and elicit a thinner fibrous 
capsule compared with random nanofibers.[28] In the present 
study, expanded nanofiber scaffolds displayed thinner fibrous 
capsules compared to 2D nanofiber membranes. Expanded 
3 and 10 mm thick scaffolds presented the similar thickness 
of fibrous capsules. The aligned expanded 3 mm thick scaf-
folds showed thinner fibrous capsules than expanded 3 and 
10 mm thick scaffolds. Expanded nanofiber scaffolds showed 
the infiltration of macrophages in different phenotypes and 
induction of heterogenous multinucleated giant cells within the 
scaffolds, which could be critical for the neovascularization and 
regeneration process.[29–33] The expanded 10 mm thick scaffolds 
had the highest number of infiltrating macrophages at week 8 
(Figure S4, Supporting Information). The number of giant cells 
per implant was comparable for expanded 3 and 10 mm thick 
scaffolds at week 4 and 8. Interestingly, expanded 3 mm thick 
scaffolds showed the highest M2/M1 ratio of multinucleated 
giant cells. In addition, the number of giant cells per implant 
for aligned 3 mm thick scaffolds was much lower compared to 
random 3 and 10 mm thick scaffolds at week 8. The multinu-
cleated giant cells present within aligned 3 mm thick scaffolds 
showed heterogeneous markers including CD 68, CCR7, and 
CD 163 similar to other scaffolds. Recent studies suggested that 
a porous polymer with interconnected pores (≈40 μm in size) 
can form vascularized tissues with little or no fibrosis and good 
resoration of vascularity, whereas the same polymer in solid 
form triggers the classic foreign body reaction characterized 
by a dense, collagen fibrous capsule and low vascularity.[34] Our 
results are in line with this finding as the expanded scaffolds 
show the distances of gaps between layers ranging from several 
micrometers to about 100 μm. Importantly, expanded nanofiber 
scaffolds showed IL-4 cytokine expression at week 1 and an 
increased IL-4 production within scaffolds with increasing 
the implantation time. Expanded 10 mm thick scaffolds dem-
onstrated the highest expression of IL-4 within scaffolds at 
week 8 among all the tested scaffolds. IL-4 could be produced by 
T helper 2 cells and guided the polarization of infiltrated mac-
rophages, providing a pro-regenerative microenvironment.[35] 
In addition, the incorporation of anti-inflammatory drugs to 
the nanofibers could further reduce the thickness of collagen 
fibrous capsules.[36] The incorporation of immunmodulating 
agents to scaffolds for sustained release could temperoally con-
trol the phenotypes of macrophages infiltrated.[37]
4. Conclusion
We have developed a robust method for producing expanded 
nanofiber scaffolds with controlled size and thickness using a 
custermized mold during the modified gas-foaming process. 
We demonstrated the evident cellular infiltration and new blood 
vessel formation within expanded nanofiber scaffolds after sub-
cutaenous implantation in rats. We also observed that expanded 
scaffolds elicited a thinner collagen fibrous capsule compared 
to unexpanded nanofiber scaffolds and promoted a regenerative 
response. Gap distances between adjacent layers, layer thick-
ness, porosity, and fiber alignment mainly determined cellular 
infiltration, vascularization, and host response. In summary, 
such expanded nanofiber scaffolds hold great potential for use 
in tissue repair/regeneration in situ, the development of various 
3D tissue models/constructs in vitro, and wound dressings.
5. Experimental Section
See the Supporting Information.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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